scholarly article | Q13442814 |
P50 | author | Lício Velloso | Q64745748 |
P2093 | author name string | William Burgess | |
Han Li | |||
Ou Wang | |||
Mark A Carlson | |||
William H Velander | |||
Yuguo Lei | |||
Eliana P Araújo | |||
Ayman Ismail | |||
Carlos Poblete Jara | |||
Thais Paulino do Prado | |||
Frank Marco Fabian | |||
P2860 | cites work | Multivalent integrin-specific ligands enhance tissue healing and biomaterial integration | Q24599082 |
Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells | Q24799386 | ||
Fibronectin Interaction and Enhancement of Growth Factors: Importance for Wound Healing | Q26798456 | ||
Cellular and molecular mechanisms of repair in acute and chronic wound healing | Q26801778 | ||
Activated protein C: A regulator of human skin epidermal keratinocyte function | Q26830499 | ||
Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin | Q27745853 | ||
Cross-talk between integrin α6β4 and insulin-like growth factor-1 receptor (IGF1R) through direct α6β4 binding to IGF1 and subsequent α6β4-IGF1-IGF1R ternary complex formation in anchorage-independent conditions | Q28114971 | ||
FAK integrates growth-factor and integrin signals to promote cell migration | Q28144169 | ||
Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms | Q28215367 | ||
Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin | Q28245806 | ||
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF | Q29615685 | ||
Integrin function: molecular hierarchies of cytoskeletal and signaling molecules | Q29618843 | ||
Cutaneous wound healing | Q29618894 | ||
Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive-a Laboratory and Clinical Perspective | Q30413860 | ||
Fibrin sealant: past, present, and future: a brief review | Q30449208 | ||
Diabetes induces stable intrinsic changes to myeloid cells that contribute to chronic inflammation during wound healing in mice | Q30557068 | ||
Plasma fibronectin supports hemostasis and regulates thrombosis | Q30590791 | ||
Biologic variability of human foreskin fibroblasts in 2D and 3D culture: implications for a wound healing model | Q30891844 | ||
The effect of fibrin sealant on the healing of laser-resurfaced skin | Q33424151 | ||
Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice | Q33537990 | ||
Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin | Q33699089 | ||
Angiogenesis in wound healing | Q33930565 | ||
Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor | Q34093942 | ||
A transitional extracellular matrix instructs cell behavior during muscle regeneration | Q34149015 | ||
Topical fibronectin therapy of persistent corneal epithelial defects. Fibronectin Study Group | Q34163974 | ||
Fibrin and wound healing. | Q34311836 | ||
Wound healing. Role of commercial fibrin sealants. | Q34311909 | ||
Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor | Q34346157 | ||
Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains | Q34392346 | ||
Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site. | Q34524158 | ||
Mesenchymal stem cell migration is regulated by fibronectin through α5β1-integrin-mediated activation of PDGFR-β and potentiation of growth factor signals | Q34727916 | ||
Integrin alpha5/beta1 mediates fibronectin-dependent epithelial cell proliferation through epidermal growth factor receptor activation | Q34735845 | ||
Spacing of integrin ligands influences signal transduction in endothelial cells | Q35218323 | ||
Macrophage PPARγ and impaired wound healing in type 2 diabetes | Q35875469 | ||
Fibronectins: multifunctional modular glycoproteins | Q36209364 | ||
Identification of the polypeptide chains involved in the cross-linking of fibrin | Q36449299 | ||
Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease | Q36520179 | ||
Dynamic structure of plasma fibronectin | Q37057966 | ||
Interactions between extracellular matrix and growth factors in wound healing | Q37423377 | ||
Selective and specific macrophage ablation is detrimental to wound healing in mice | Q37462741 | ||
The pleiotropic role of the fibrinogen gamma' chain in hemostasis | Q37581345 | ||
Defining stem cell dynamics and migration during wound healing in mouse skin epidermis. | Q37684051 | ||
Fibrin polymerization and its regulatory role in hemostasis | Q37943611 | ||
Role of fibronectin in normal wound healing | Q38112462 | ||
Fibronectin at select sites binds multiple growth factors and enhances their activity: expansion of the collaborative ECM-GF paradigm | Q38171137 | ||
Myeloid cell dysfunction and the pathogenesis of the diabetic chronic wound | Q38222361 | ||
Covalent cross-linking of fibronectin to fibrin is required for maximal cell adhesion to a fibronectin-fibrin matrix | Q38342850 | ||
Cell sensing of physical properties at the nanoscale: Mechanisms and control of cell adhesion and phenotype. | Q38643994 | ||
The role of biophysical properties of provisional matrix proteins in wound repair | Q38930117 | ||
Chronic Wound Healing: A Review of Current Management and Treatments. | Q39097188 | ||
Diabetic Foot Ulcers and Their Recurrence | Q39373687 | ||
Differential Staining of Collagens Type I, II and III by Sirius Red and Polarization Microscopy | Q39518655 | ||
Matrix stiffening sensitizes epithelial cells to EGF and enables the loss of contact inhibition of proliferation | Q39571912 | ||
A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme M-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes. | Q39837612 | ||
Physiology of Fibronectin | Q40142052 | ||
Cell adhesion and motility depend on nanoscale RGD clustering. | Q40886208 | ||
Topical Fibronectin Improves Wound Healing of Irradiated Skin | Q41081313 | ||
Role of fibronectin in the migration of fibroblasts into plasma clots | Q41506997 | ||
Tissue-scale coordination of cellular behaviour promotes epidermal wound repair in live mice | Q41594189 | ||
Mutual cross-talk between fibronectin integrins and the EGF receptor: Molecular basis and biological significance | Q42174975 | ||
Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains | Q42194253 | ||
Neutrophils and Wound Repair: Positive Actions and Negative Reactions | Q42585272 | ||
Changes in cell spreading and cytoskeletal organization are induced by adhesion to a fibronectin-fibrin matrix. | Q42811525 | ||
Fibronectin Growth Factor-Binding Domains Are Required for Fibroblast Survival | Q42825954 | ||
Nanopatterning of fibronectin and the influence of integrin clustering on endothelial cell spreading and proliferation | Q43502346 | ||
Studies in fetal wound healing: III. Early deposition of fibronectin distinguishes fetal from adult wound healing | Q44788260 | ||
The mouse excisional wound splinting model, including applications for stem cell transplantation | Q44804631 | ||
Activation of integrin function by nanopatterned adhesive interfaces | Q44832858 | ||
A totally recombinant human fibrin sealant | Q44840788 | ||
Thrombin as important factor for cutaneous wound healing: comparison of fibrin biomatrices in vitro and in a rat excisional wound healing model. | Q45130928 | ||
Fibronectin alters the rate of formation and structure of the fibrin matrix. | Q45903024 | ||
Scarless wound healing: Transitioning from fetal research to regenerative healing | Q47561285 | ||
Fibronectin fragments modulate human retinal capillary cell proliferation and migration | Q47690693 | ||
.gamma. and .gamma.' chains of human fibrinogen are produced by alternative mRNA processing | Q48388090 | ||
Suppressed recruitment of alternatively activated macrophages reduces TGF-β1 and impairs wound healing in streptozotocin-induced diabetic mice. | Q51008715 | ||
Production-scale fibronectin nanofibers promote wound closure and tissue repair in a dermal mouse model. | Q52651009 | ||
Fibrin sealant combined with fibroblasts and platelet-derived growth factor enhance wound healing in excisional wounds. | Q53379160 | ||
Topical application of plasma fibronectin in full-thickness skin wound healing in rats. | Q53543085 | ||
Direct conversion of injury-site myeloid cells to fibroblast-like cells of granulation tissue. | Q55008802 | ||
The Role of Macrophages in Acute and Chronic Wound Healing and Interventions to Promote Pro-wound Healing Phenotypes. | Q55025127 | ||
Current Challenges and Opportunities in the Prevention and Management of Diabetic Foot Ulcers | Q58647336 | ||
Fibronectin and fibrin gel structure | Q69856283 | ||
Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization | Q71446276 | ||
Specificity of fibronectin--fibrin cross-linking | Q72557144 | ||
Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation | Q73219902 | ||
Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix | Q73303260 | ||
Potentiation of endothelial cell proliferation by fibrin(ogen)-bound fibroblast growth factor-2 | Q77754804 | ||
Effects of plasma fibronectin on the healing of full-thickness skin wounds in streptozotocin-induced diabetic rats | Q79426007 | ||
Fibronectin potentiates topical erythropoietin-induced wound repair in diabetic mice | Q83422958 | ||
Wound healing effect of regenerated oxidized cellulose versus fibrin sealant patch: An in vivo study | Q90973293 | ||
A totally recombinant fibrin matrix for mesenchymal stem cell culture and delivery | Q91172923 | ||
Reversible associations between human plasma fibronectin and fibrinogen γγ' heterodimer observed by high pressure size exclusion chromatography and dynamic light scattering | Q91730224 | ||
A model for fibrinogen: domains and sequence | Q93653228 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 4 | |
P921 | main subject | wound healing | Q1509074 |
P304 | page(s) | 949-962 | |
P577 | publication date | 2020-07-01 | |
P1433 | published in | Bioactive Materials | Q50817670 |
P1476 | title | Novel fibrin-fibronectin matrix accelerates mice skin wound healing | |
P478 | volume | 5 |
Search more.